Abstract
A new immunoblot assay, composed of four Epstein-Barr virus (EBV)- encoded recombinant proteins (virus capsid antigen [VCA] p23, early antigen [EA] p138, EA p54, and EBNA-1 p72), was compared with an immunofluorescence assay on a total of 291 sera. The test was accurate in 94.5% of cases of primary EBV infection, while an immunoglobulin G anti-VCA p23 band with strong intensity correlated with reactivation.
Cite
CITATION STYLE
Buisson, M., Fleurent, B., Mak, M., Morand, P., Chan, L., Ng, A., … Seigneurin, J. M. (1999). Novel immunoblot assay using four recombinant antigens for diagnosis of Epstein-Barr virus primary infection and reactivation. Journal of Clinical Microbiology, 37(8), 2709–2714. https://doi.org/10.1128/jcm.37.8.2709-2714.1999
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.
